SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-016221
Filing Date
2023-05-01
Accepted
2023-05-01 16:01:34
Documents
18

Document Format Files

Seq Description Document Type Size
1 DEF 14A vktx-20230501.htm   iXBRL DEF 14A 1123774
2 GRAPHIC img253240217_0.jpg GRAPHIC 398611
3 GRAPHIC img253240217_1.jpg GRAPHIC 358396
4 GRAPHIC img253240217_2.jpg GRAPHIC 83779
5 GRAPHIC img253240217_3.jpg GRAPHIC 122829
  Complete submission text file 0000950170-23-016221.txt   3919537

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vktx-20230501_pre.xml EX-101.PRE 9079
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vktx-20230501_lab.xml EX-101.LAB 15040
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vktx-20230501.xsd EX-101.SCH 6267
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vktx-20230501_def.xml EX-101.DEF 7402
12 EXTRACTED XBRL INSTANCE DOCUMENT vktx-20230501_htm.xml XML 171931
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37355 | Film No.: 23873437
SIC: 2834 Pharmaceutical Preparations